News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Nieves Martinez Lago: NETs/NENs Gain Dedicated Category at ASCO GI26
Aug 20, 2025, 15:57

Nieves Martinez Lago: NETs/NENs Gain Dedicated Category at ASCO GI26

Nieves Martinez Lago, Specialist in the Field (FEA) of Medical Oncology at University Hospital Complex of Santiago de Compostela, shared a post on X by Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport Academy Medical Centre, adding:

“Great news Having NETs/NENs as their own category at GI26 ASCO is a key step to increase visibility, foster collaborative research, and improve patient outcomes.”

Quoting Udhayvir Grewal‘s post:

“So happy to see NETs/NENs as an abstract submission category for next year’s ASCO GI symposium (GI26). With the rising incidence of NETs and rapid advances in diagnosis and treatment, it is so important that we encourage more research and collaborative efforts to help improve outcomes in this space.”

Image

More featuring posts Nieves Martinez Lago and Udhayvir Grewal on OncoDaily.

ASCO cancer GI symposium GI26 NETs/NENs Nieves Martinez Lago OncoDaily Oncology Udhayvir Grewal
Special Coverage
Voices
Aug 20, 2025, 15:57
Nieves Martinez Lago: NETs/NENs Gain Dedicated Category at ASCO GI26
Science
Aug 20, 2025, 15:55
ASCO25 Liquid Biopsy Highlights - International Society of Liquid Biopsy
Voices
Aug 20, 2025, 15:54
Chrystal Paulos Has Been Awarded V Foundation All-Star Grant - Winship Cancer Institute of Emory University
Voices
Aug 20, 2025, 15:52
Kirsten Efremov: Strengthening Patient Engagement in the Adolescent and Young Adult Cancer Community
Insight
Aug 20, 2025, 15:42
Joshua Palmer: Pre-Operative Versus Post-Operative Fractionated Stereotactic Radiotherapy
Immune Oncology
Aug 20, 2025, 15:42
New IO Paper Alert: Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for First-Line Immunotherapy Outcomes in HCC.
Voices
Aug 20, 2025, 15:41
Rob Winn: The NIH's 15% Indirect Cost Cap - A Misunderstanding of Research Reality
Opinion
Aug 20, 2025, 15:36
Elisabeth Potter: The Impact of Rising Insurance Costs on Breast Cancer Treatment Choices
Voices
Aug 20, 2025, 15:32
Minhua Chu: BNT327 (Pumitamig) Shows Promising Efficacy in ES-SCLC in Phase II Trial
Dialogues
Aug 20, 2025, 15:27
How Can We Accelerate New Drug Development for Children with Cancer? | Second Global Oncothon
Voices
Aug 20, 2025, 15:24
The Role of Radiotherapy and AI in Cancer Treatment at National Summit - National Cancer Institute of Kenya
Dialogues
Aug 20, 2025, 15:22
How Can We Better Manage GI Side Effects from New Cancer Therapies? | MASCC 2025